自动乳腺超声系统在评估乳腺磁共振纯非肿块强化中的效用与诊断性能
本研究比较自动乳腺超声系统(ABUS)与手持超声(HHUS)评估乳腺磁共振纯非肿块强化(NME)病变的效用与诊断性能,纳入126个纯NME病变(100个恶性,26个良性)。ABUS与HHUS的NME相关率分别为87.3%和92.9%,敏感度87%对92%、特异度50%对42.3%,均无显著差异。ABUS对恶性NME的显示率显著高于良性(93%对65.4%,p=0.001),病变大小、分布模式及乳腺X线微钙化与ABUS显示相关。
要点
- ABUS对乳腺MRI纯NME病变显示率为87.3%,与HHUS的92.9%相近,诊断性能相当。
- ABUS对恶性NME显示率93%,显著高于良性NME的65.4%(p=0.001)。
- MRI上病变大小、分布模式及乳腺X线微钙化与ABUS显示NME相关。
关键影像表现/征象
- 126个纯NME病变中100个(79.4%)为恶性,26个(20.6%)为良性。
- ABUS对恶性NME的显示率93%高于良性NME的65.4%(p=0.001)。
- 与ABUS显示相关的因素包括MRI上NME病变大小(p<0.001)、分布模式(p<0.001)及乳腺X线微钙化(p=0.027)。
诊断标准与关键数值
- ABUS的NME相关率为87.3%(110/126),HHUS为92.9%(117/126)。
- ABUS敏感度87%、特异度50%;HHUS敏感度92%、特异度42.3%,差异无统计学意义(p=0.180和0.727)。
临床应用与阅片要点
- ABUS可用于评估乳腺MRI显示的纯NME病变,对恶性病变更易显示。
- ABUS与HHUS诊断性能相当,可作为评估NME的超声手段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the utility and diagnostic performance of automated breast ultrasound system (ABUS) with that of hand-held ultrasound (HHUS) in evaluating pure non-mass enhancement (NME) lesions on breast magnetic resonance imaging (MRI).
MATERIALS AND METHODS: One hundred twenty-six consecutive MRI-visible pure NME lesions of 122 patients with breast cancer were assessed from April 2016 to March 2017. Two radiologists reviewed the preoperative breast MRI, ABUS, and HHUS images along with mammography (MG) findings. The NME correlation rate and diagnostic performance of ABUS were compared with that of HHUS, and the imaging features associated with ABUS visibility were analyzed.
RESULTS: Among 126 pure NME lesions, 100 (79.4%) were malignant and 26 (20.6%) were benign. The overall correlation rate was 87.3% (110/126) in ABUS and 92.9% (117/126) in HHUS. The sensitivity and specificity were 87% and 50% for ABUS and 92% and 42.3% for HHUS, respectively, with no significant differences (p = 0.180 and 0.727, respectively). Malignant NME was more frequently visualized than benign NME lesions on ABUS (93% vs. 65.4%, p = 0.001). Significant factors associated with the visibility of ABUS were the size of NME lesions on MRI (p < 0.001), their distribution pattern (p < 0.001), and microcalcifications on MG (p = 0.027).
CONCLUSION: ABUS evaluation of pure NME lesions on MRI in patients with breast cancer is a useful technique with high visibility, especially in malignant lesions. The diagnostic performance of ABUS was comparable with that of conventional HHUS in evaluating NME lesions.
引用
- Kwon BR, Chang JM, Kim SY, et al. Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging. Korean J Radiol. 2020. PMID: 32729267. doi:10.3348/kjr.2019.0881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。